Greenleaf Trust’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Buy
1,964
+506
+35% +$72.1K ﹤0.01% 756
2025
Q4
$243K Buy
1,458
+136
+10% +$22.8K ﹤0.01% 727
2025
Q3
$259K Buy
+1,322
New +$217K ﹤0.01% 700

Other funds holding ALAB

Greenleaf Trust's ALAB Position: Q1 2026 in Review

Greenleaf Trust increased its Astera Labs (ALAB) stake by 35% in Q1 2026, buying an estimated $72.1K and bringing the position to 1,964 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #756.

Greenleaf Trust first reported a position in ALAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $259K in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Greenleaf Trust held 1,964 shares of Astera Labs worth $215K as of Q1 2026.
  • Greenleaf Trust bought 506 Astera Labs shares in Q1 2026, an estimated $72.1K.
  • Astera Labs made up ﹤0.01% of Greenleaf Trust's portfolio in Q1 2026, its #756 holding.
  • Greenleaf Trust first reported a position in Astera Labs in Q3 2025 and has held it in 3 quarters since.
  • Greenleaf Trust's Astera Labs position peaked at $259K in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.